Thomas Ichim
Senior Research Consultant
Veterinary Sciences
Zander Therapeutics
United States of America
Biography
Dr. Ichim has extensive experience with stem cell therapy and cellular product development through FDA regulatory pathways. He spent over seven years as President and Chief Scientific Officer of Medistem, developing and commercializing a novel stem cell, the Endometrial Regenerative Cell, through drug discovery, optimization, preclinical testing.
Research Interest
Veterinary Sciences
